Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Reid

Showing results (241-250 of 589) with videos related to

Pageof 59
Sort By:
Journal of Hypertension|July 19, 2023
Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysisMaame Esi Woode, Kristina Wong, Christopher M Reid, et al.
Elife|December 1, 2021
Transcriptional profiling of sequentially generated septal neuron fatesMiguel Turrero García, Sarah K Stegmann, Tiara E Lacey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2017
Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarctionMatias B Yudi, Omar Farouque, Nick Andrianopoulos, et al.
Heart, Lung & Circulation|February 12, 2025
A Comparison of Prescribing Guideline-Advocated Treatment for Heart Failure at Discharge from Cardiology and Non-Cardiology WardsLiying Dai, Tashi Dorje, Jan Gootjes, et al.
Cardiovascular Drugs and Therapy|January 20, 2018
Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group RegistryKen Lee Chin, Rory Wolfe, Christopher M Reid, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 14, 2024
Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years - Melbourne interventional group (MIG) registryPouya Nezafati, Andrew Ajani, Diem Dinh, et al.
ESC Heart Failure|August 19, 2022
Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older personsStephanie M Liew, Enayet K Chowdhury, Michael E Ernst, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
A developmentally defined population of neurons in the lateral septum controls responses to aversive stimuliMiguel Turrero García, Diana N Tran, Ralph E Peterson, et al.
Journal of Clinical Medicine|October 14, 2020
Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary InterventionSinjini Biswas, Diem Dinh, Mark Lucas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 3, 2022
Health-related quality of life following percutaneous coronary intervention during the COVID-19 pandemicLuke P Dawson, Diem T Dinh, Dion Stub, et al.
Pageof 59

Showing results (241-250 of 589) with videos related to

Sort By:
Pageof 59
Journal of Hypertension|July 19, 2023
Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysisMaame Esi Woode, Kristina Wong, Christopher M Reid, et al.
Elife|December 1, 2021
Transcriptional profiling of sequentially generated septal neuron fatesMiguel Turrero García, Sarah K Stegmann, Tiara E Lacey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2017
Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarctionMatias B Yudi, Omar Farouque, Nick Andrianopoulos, et al.
Heart, Lung & Circulation|February 12, 2025
A Comparison of Prescribing Guideline-Advocated Treatment for Heart Failure at Discharge from Cardiology and Non-Cardiology WardsLiying Dai, Tashi Dorje, Jan Gootjes, et al.
Cardiovascular Drugs and Therapy|January 20, 2018
Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group RegistryKen Lee Chin, Rory Wolfe, Christopher M Reid, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 14, 2024
Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years - Melbourne interventional group (MIG) registryPouya Nezafati, Andrew Ajani, Diem Dinh, et al.
ESC Heart Failure|August 19, 2022
Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older personsStephanie M Liew, Enayet K Chowdhury, Michael E Ernst, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
A developmentally defined population of neurons in the lateral septum controls responses to aversive stimuliMiguel Turrero García, Diana N Tran, Ralph E Peterson, et al.
Journal of Clinical Medicine|October 14, 2020
Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary InterventionSinjini Biswas, Diem Dinh, Mark Lucas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 3, 2022
Health-related quality of life following percutaneous coronary intervention during the COVID-19 pandemicLuke P Dawson, Diem T Dinh, Dion Stub, et al.
Pageof 59